← All legislation

2025-2026 Regular Session

HF2906

Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated.

Earlier-session bill · introduced 2025

Legislative progress

i

This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.

Introduced in House March 27, 2025

Committee referrals

Instrument history

i

This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.

  1. House Author added Rymer
  2. House Committee report, to adopt as amended and re-refer to Commerce Finance and Policy
  3. House Authors added Repinski and Lee, X.
  4. House Author added West as second author
  5. House Author added Sencer-Mura
  6. House Introduction and first reading, referred to Health Finance and Policy
Source provenance